as for patients with neurological improvement, 1 mg IM OH-Cbl on alternate days until there is no clinical improvement and then maintenance 1 mg IM OH-Cbl every 2 months is recommended (NICE, 2022)
The mechanism involves an increase in GLUT4 transporter expression, improving glucose uptake
Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
If you are considering switching between peptides, understanding the concentration differences prevents the kind of dosing confusion that happens when people apply one peptide dose chart to a different peptide
CoQ10 Shots Coenzyme Q10 is an antioxidant that is essential for producing energy in cells
The role of SeekPeptides in your injection journey Proper injection technique is essential for results
